Epigenetic inactivation of RUNX3 in colorectal cancer

다국어 초록 (Multilingual Abstract)

Purpose: The purpose of this study was to evaluate the efficacy of Betafoam in terms of wound healing and safety.
Methods: Fifty-four male adult Sprague-Dawley rats (weight, 200–250 g) were used in the study. Full-thickness skin defects were created on the back of each rats. The rats were assigned to 6 groups according to the type of wound dressing used (n = 9 for each group): Betafoam, Allevyn-Ag, Mepilex-Ag, Medifoam silver, Polymem-Ag, and gauze. The wound size, histological findings, and amount of DNA on the changed dressings for each group were analyzed and compared.
Results: All groups showed an effective decrease in wound size. However, the differences between Betafoam and the other dressings were statistically significant on day 14 (P < 0.05). The number of newly generated blood vessels in the Betafoam group was significantly higher than in the gauze, Allevyn-Ag, and Medifoam silver groups (P < 0.001). In the Betafoam group, the proportion of collagen deposition was highest and showed a significantly superior arrangement of collagen fibers compared with the gauze, Allevyn-Ag, Mepilex-Ag, and Medifoam silver groups. The total content of the remaining DNA counts of the exchanged dressings were significantly lower in the Betafoam group than the others.
Conclusion: Betafoam is effective in wound healing and provides the best performance amongst the various types of dressing materials in terms of re-epithelialization, angiogenesis, collagen deposition, and tissue invasion.

목차 (Table of Contents)

• INTRODUCTION
• METHODS
• RESULTS
• DISCUSSION
• REFERENCES

참고문헌 (Reference)

1 Guo C, "Tumor suppressor gene Runx3 sensitizes gastric cancer cells to chemotherapeutic drugs by downregulating Bcl-2, MDR-1 and MRP-1" 116 : 155-160, 2005

2 Bae SC, "Tumor suppressor activity of RUNX3" 23 : 4336-4340, 2004

3 Li QL, "Transcriptional silencing of the RUNX3 gene by CpG hypermethylation is associated with lung cancer" 314 : 223-228, 2004

4 Soong R, "The expression of RUNX3 in colorectal cancer is associated with disease stage and patient outcome" 100 : 676-679, 2009

5 Levanon D, "Runx3 knockouts and stomach cancer" 4 : 560-564, 2003

6 Chi XZ, "RUNX3 suppresses gastric epithelial cell growth by inducing p21(WAF1/Cip1) expression in cooperation with transforming growth factor {beta}-activated SMAD" 25 : 8097-8107, 2005

7 Nishio M, "RUNX3 promoter methylation in colorectal cancer: its relationship with microsatellite instability and its suitability as a novel serum tumor marker" 30 : 2673-2682, 2010

8 Torquati A, "RUNX3 inhibits cell proliferation and induces apoptosis by reinstating transforming growth factor beta responsiveness in esophageal adenocarcinoma cells" 136 : 310-316, 2004

9 Ito Y, "RUNX transcription factors as key targets of TGF-beta superfamily signaling" 13 : 43-47, 2003

10 Ozaki T, "RUNX family participates in the regulation of p53-dependent DNA damage response" 2013 : 271347-, 2013

11 Ku JL, "Promoter hypermethylation downregulates RUNX3 gene expression in colorectal cancer cell lines" 23 : 6736-6742, 2004

12 Kato N, "Hypermethylation of the RUNX3 gene promoter in testicular yolk sac tumor of infants" 163 : 387-391, 2003

13 박원상, "Hypermethylation of the RUNX3 gene in hepatocellular carcinoma" 생화학분자생물학회 37 (37): 276-281, 2005

14 Xiao WH, "Hemizygous deletion and hypermethylation of RUNX3 gene in hepatocellular carcinoma" 10 : 376-380, 2004

15 Nakase Y, "Frequent loss of RUNX3 gene expression in remnant stomach cancer and adjacent mucosa with special reference to topography" 92 : 562-569, 2005

16 Oshimo Y, "Frequent loss of RUNX3 expression by promoter hypermethylation in gastric carcinoma" 71 : 137-143, 2004

17 Osaki M, "Expression of RUNX3 protein in human gastric mucosa, intestinal metaplasia and carcinoma" 34 : 605-612, 2004

18 Lao VV, "Epigenetics and colorectal cancer" 8 : 686-700, 2011

19 Goel A, "Epigenetic inactivation of RUNX3 in microsatellite unstable sporadic colon cancers" 112 : 754-759, 2004

20 Fukushige S, "DNA methylation in cancer: a gene silencing mechanism and the clinical potential of its biomarkers" 229 : 173-185, 2013

21 Ogino S, "CpG island methylation, response to combination chemotherapy, and patient survival in advanced microsatellite stable colorectal carcinoma" 450 : 529-537, 2007

22 Mu WP, "Clinical significance and association of RUNX3 hypermethylation frequency with colorectal cancer: a meta-analysis" 7 : 1237-1245, 2014

23 Li QL, "Causal relationship between the loss of RUNX3 expression and gastric cancer" 109 : 113-124, 2002

24 Siegel R, "Cancer statistics, 2014" 64 : 9-29, 2014